Biolinq

The Revolutionary Biosensing Platform for Metabolic Health.

General Information
Company Name
Biolinq
Founded Year
2012
Location (Offices)
San Diego, United States +1
Founders / Decision Makers
Number of Employees
101
Industries
Biotechnology, Hardware, Health Care +1
Funding Stage
Series D
Social Media

Biolinq - Company Profile

Biolinq is a biotechnology startup founded in 2012 in the United States that aims to revolutionize metabolic health monitoring with its biosensing platform. The company's innovative approach involves the use of an array of electrochemical sensors that are designed to be minimally invasive, providing a new biowearable experience. This technology enables continuous sensing of multiple analytes such as glucose, ketones, and lactate, offering users actionable insights into their metabolic health. In April 2024, Biolinq secured a significant $58.00M Venture Round investment from a diverse group of investors including RiverVest, Pegasus Tech Ventures, Senvest Capital, Aphelion Capital, Global Health Investment Corporation, Niterra Ventures, Taisho Pharmaceutical Holdings, Features Capital, Alpha Wave Ventures, and AXA Investment Managers. This funding injection signifies a strong show of confidence from the investor community in Biolinq's vision and technology. With a focus on biotechnology and healthcare industries, Biolinq is well-positioned to tap into the growing demand for innovative solutions in the health tech space. The company's commitment to creating a positive and creative work environment, as well as its dedication to the personal and professional growth of its team members, underscores its focus on fostering a strong internal culture. Looking to the future, Biolinq's ambitions extend to bringing biosensing and biowearables into the mainstream over the next 10 years, signaling its long-term vision and determination to make a significant impact in the healthcare technology sector.

Taxonomy: Biosensing, Biowearable, Metabolic health, Electrochemical sensors, Continuous sensing, Glucose monitoring, Ketone monitoring, Lactate monitoring, Health insights, Biotech innovation, Technology startup, Personal growth, Positive work environment

Funding Rounds & Investors of Biolinq (9)

View All
Funding Stage Amount No. Investors Investors Date
Series D $58.00M 10 Taisho Pharmaceutical Holdings, Niterra Ventures +3 04 Apr 2024
Venture Round $77.95M - 07 May 2022
Series B $100.00M 10 T&W Medical, Taisho Pharmaceutical Holdings 02 Nov 2021
Debt Financing $3.55M - 25 Mar 2020
Series A $4.75M 5 28 Mar 2019

View All 9 Funding Rounds

Similar Companies to Biolinq

View All
Metabolic Health Solutions - Similar company to Biolinq
Metabolic Health Solutions Taking Metabolism Testing to the World
Veri (acquired by ŌURA) - Similar company to Biolinq
Veri (acquired by ŌURA) Understand what to eat
Nutrisense - Similar company to Biolinq
Nutrisense On a mission to help you reach your health potential
Spire Health - Similar company to Biolinq
Spire Health Spire Health is a global leader in delivering continuous health-sensing solutions.
Keto-Mojo - Similar company to Biolinq
Keto-Mojo Improve Patient Health Outcomes through Nutrition | FDA-Approved Ketone and Glucose Meter | Remote Patient Monitoring